CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹28 Cr | ₹23 Cr | ₹21 Cr | ₹17 Cr | ₹15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CONCORD BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹28 Cr |
Mar2023 | ₹23 Cr |
Mar2022 | ₹21 Cr |
Mar2021 | ₹17 Cr |
Mar2020 | ₹15 Cr |
How is Deferred Tax Assets / Liabilities of CONCORD BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹28 Cr | 19.74 | |
Mar2023 | ₹23 Cr | 11.77 | |
Mar2022 | ₹21 Cr | 20.16 | |
Mar2021 | ₹17 Cr | 15.37 | |
Mar2020 | ₹15 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹19,845.8 Cr | 3.2% | 4.1% | 14.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 3.2% |
4.1% |
14.7% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses